"Atovaquone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A hydroxynaphthoquinone that has antimicrobial activity and is being used in antimalarial protocols.
Descriptor ID |
D053626
|
MeSH Number(s) |
D02.806.550.312 D04.615.638.721.186
|
Concept/Terms |
Atovaquone- Atovaquone
- 2-(4-(4'-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
- 2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
566C80- 566C80
- hydroxynaphthoquinone 566C80
- 566C80 hydroxynaphthoquinone
- hydroxynaphthoquinone, 566C80
|
Below are MeSH descriptors whose meaning is more general than "Atovaquone".
Below are MeSH descriptors whose meaning is more specific than "Atovaquone".
This graph shows the total number of publications written about "Atovaquone" by people in this website by year, and whether "Atovaquone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2015 | 0 | 1 | 1 |
2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Atovaquone" by people in Profiles.
-
Stevens AM, Xiang M, Heppler LN, Tošic I, Jiang K, Munoz JO, Gaikwad AS, Horton TM, Long X, Narayanan P, Seashore EL, Terrell MC, Rashid R, Krueger MJ, Mangubat-Medina AE, Ball ZT, Sumazin P, Walker SR, Hamada Y, Oyadomari S, Redell MS, Frank DA. Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation. Blood Adv. 2019 12 23; 3(24):4215-4227.
-
Petty LA, Qamar S, Ananthanarayanan V, Husain AN, Murks C, Potter L, Kim G, Pursell K, Fedson S. Cardiac toxoplasmosis after heart transplantation diagnosed by endomyocardial biopsy. Transpl Infect Dis. 2015 Oct; 17(5):719-22.
-
Hughes WT, Dankner WM, Yogev R, Huang S, Paul ME, Flores MA, Kline MW, Wei LJ. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection. Clin Infect Dis. 2005 Jan 01; 40(1):136-45.